Anti-snoring Devices and Snoring Surgery Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031F

Chin Straps is the fastest growing sector, North America is the largest market

The global market for anti-snoring devices and snoring surgery is projected to expand significantly, from USD 1.72 Billion in 2025 to USD 2.69 Billion by 2031, demonstrating a compound annual growth rate of 7.74%. This sector encompasses a range of solutions including non-invasive devices such as oral appliances, nasal dilators, and continuous positive airway pressure (CPAP) machines designed to ensure open airways, as well as surgical procedures aimed at correcting structural obstructions causing snoring. The primary drivers behind this expansion are the increasing worldwide prevalence of obesity and the growing elderly population, both demographics being highly prone to sleep-disordered breathing.

For instance, the National Council on Aging reported that by 2025, approximately 56% of adults aged 65 and above face a high risk of developing obstructive sleep apnea, underscoring the strong link between age and sleep disorders and the resulting consistent demand for effective therapeutic options, both surgical and non-surgical. However, a key impediment to market growth is the challenge of patient adherence and comfort with these devices. A notable number of users experience discomfort or claustrophobia from CPAP masks or mandibular advancement devices, leading to high rates of therapy abandonment. This resistance to long-term treatment protocols restricts potential revenue for manufacturers and poses a significant hurdle to the widespread adoption of anti-snoring technologies globally.

Market Drivers

The primary catalyst for market expansion is the escalating global incidence of Obstructive Sleep Apnea (OSA), largely driven by rising obesity rates and an aging worldwide population. As lifestyle-related respiratory ailments become more common, the number of individuals needing clinical intervention significantly increases, thereby boosting demand for advanced diagnostic tools and therapeutic options. This growing health burden is exemplified by projections, such as ResMed's August 2025 press release stating that OSA is expected to impact approximately 77 million U.S. adults by 2050. This surge in OSA prevalence directly translates into increased commercial activity and financial growth for leading companies in the industry.

Reflecting this economic impact, ResMed reported a quarterly revenue of $1.3 billion in 2025, fueled by consistent demand for sleep health devices and masks. Concurrently, a substantial increase in demand for minimally invasive surgical interventions is reshaping treatment approaches, especially for patients who struggle with adherence to conventional non-invasive therapies.

Surgical alternatives like hypoglossal nerve stimulation are gaining popularity, providing lasting solutions for anatomical obstructions without the discomfort often associated with continuous positive airway pressure (CPAP) machines. Technological advancements further expedite the adoption of these procedures by enhancing patient outcomes and simplifying surgical complexity. For example, Inspire Medical Systems reported in November 2025 that over 75% of clinical centers were prepared to adopt their new Inspire V system, indicating a significant move towards advanced, minimally invasive treatments as a preferred method for managing severe sleep disorders.

Market Challenges

Patient adherence presents a significant obstacle to revenue generation in the anti-snoring and sleep surgery market. Although the widespread occurrence of sleep disorders suggests a broad adoption of treatment devices, the invasive nature of conventional therapies, particularly continuous positive airway pressure (CPAP) masks and mandibular advancement devices, often creates considerable resistance. Users frequently report physical discomfort, claustrophobia, and sleep disturbances directly attributable to the equipment, resulting in high rates of therapy discontinuation soon after diagnosis. This non-compliance with prescribed treatment directly impacts the recurring revenue streams crucial for manufacturers of consumable parts and long-term therapeutic hardware.

The extensive scale of this non-adherence substantially shrinks the achievable total addressable market. Data from the National Sleep Foundation in 2025 revealed that nearly 31% of adults diagnosed with sleep apnea were not actively undergoing treatment. This statistic highlights that a large portion of the diagnosed patient population effectively withdraws from the market due to discomfort or an unwillingness to continue therapy. Consequently, despite increasing diagnosis rates, the industry faces difficulty in converting patient awareness into consistent product usage, thereby impeding potential financial growth and restricting the overall market penetration of anti-snoring technologies.

Market Trends

A significant shift is occurring with the emergence of daytime neuromuscular stimulation therapies, moving away from conventional nighttime interventions towards active muscle strengthening during waking hours. Unlike continuous positive airway pressure (CPAP) machines or oral appliances that require use during sleep, these innovative therapies employ neuromuscular electrical stimulation to enhance the endurance of upper airway muscles while the patient is awake. This method directly tackles the underlying cause of airway collapse without the physical burden of nocturnal devices, thus substantially improving patient adherence. Signifier Medical Technologies, for instance, reported in February 2025 that clinical data for their eXciteOSA daytime therapy shows adherence rates exceeding 80%, confirming its potential to resolve the persistent non-compliance issues associated with standard sleep apnea treatments.

Concurrently, the increasing adoption of 3D-printed custom mandibular devices is transforming oral appliance therapy through advanced precision engineering and improved biocompatibility. Manufacturers are now utilizing medical-grade 3D printing to produce highly personalized splints that offer superior structural integrity and greater comfort compared to older thermoformed devices. These advanced appliances are specifically designed to reduce intraoral bulk, thereby minimizing the chance of jaw discomfort and promoting more natural tongue placement. Highlighting this technological advancement, ProSomnus Sleep Technologies announced in June 2025 the launch of their EVO Guided device, a bioengineered solution that provides up to 14 times more tongue space than previous devices, a crucial feature for improving airway patency and ensuring patient comfort during extended use.

Key Market Players

• Apnea Sciences Corp.
• SomnoMed Ltd.
• Airway Management, Inc.
• ResMed Inc.
• Fisher & Paykel Healthcare Corp. Ltd.
• Koninklijke Philips NV
• Sleep Well Enjoy Life, Ltd.
• Tomed Dr. Toussaint GmbH
• MEDiTAS Ltd.
• Sleeping Well, LLC

Report Scope

In this report, the Global Anti-snoring Devices and Snoring Surgery Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Anti-snoring Devices and Snoring Surgery Market, by Type:

• Oral Appliances/Mouthpieces
• Nasal Devices
• Position Control Devices
• Chin Straps
• Tongue Stabilizing Devices
• EPAP Therapy Devices

Anti-snoring Devices and Snoring Surgery Market, by Region:

• North America
• Europe
• Asia Pacific
• South America
• Middle East & Africa

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Anti-snoring Devices and Snoring Surgery Market.

Available Customizations:

With the given market data, the publisher offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

This product will be delivered within 1-3 business days.